Tissue-type Plasminogen Activator (tPA) promotes M1 macrophage survival through p90 Ribosomal S6 Kinase (RSK) and p38 Mitogen-activated Protein Kinase (MAPK) pathway

Journal of Biological Chemistry

Volumn 290, Issue 12, 2015, Pages 7910-7917

  Lin, Ling ^a   Jin, Yang ^b   Hu, Kebin ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CELL SIGNALING; CHEMICAL COMPOUNDS; ENZYMES; MAMMALS; PROTEINS; TISSUE;

CHEMOKINE EXPRESSION; CYTOPROTECTIVE EFFECTS; LIPOPOLYSACCHARIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASE; P90 RIBOSOMAL S6 KINASE; SPECIFIC INHIBITORS; TISSUE-TYPE PLASMINOGEN ACTIVATOR (TPA); UNILATERAL URETERAL OBSTRUCTIONS;

MACROPHAGES;

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; S6 KINASE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; M1 MACROPHAGE; M2 MACROPHAGE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CYTOLOGY; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; CELL LINE; MACROPHAGES; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84925310803     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.599688     Document Type: Article

References (42)

1. Ricardo, S. D., van Goor, H., and Eddy, A. A. (2008) Macrophage diversity in renal injury and repair. J. Clin. Invest. 118, 3522-3530
2. Wang, Y., and Harris, D. C. (2011) Macrophages in renal disease. J. Am. Soc. Nephrol. 22, 21-27
3. Zhang, M. Z., Yao, B., Yang, S., Jiang, L., Wang, S., Fan, X., Yin, H., Wong, K., Miyazawa, T., Chen, J., Chang, I., Singh, A., and Harris, R. C. (2012) CSF-1 signaling mediates recovery from acute kidney injury. J. Clin. Invest. 122, 4519-4532
4. Gordon, S., and Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964
5. Steinberg, B. E., and Grinstein, S. (2008) Pathogen destruction versus intracellular survival: the role of lipids as phagosomal fate determinants. J. Clin. Invest. 118, 2002-2011
6. Marriott, H. M., Bingle, C. D., Read, R. C., Braley, K. E., Kroemer, G., Hellewell, P. G., Craig, R. W., Whyte, M. K., and Dockrell, D. H. (2005) Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance. J. Clin. Invest. 115, 359-368
7. Mosser, D. M., and Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969
8. Hu, K., Lin, L., Tan, X., Yang, J., Bu, G., Mars, W. M., and Liu, Y. (2008) tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosis. J. Am. Soc. Nephrol. 19, 503-514
9. Hu, K., Mars, W. M., and Liu, Y. (2008) Novel actions of tissue-type plasminogen activator in chronic kidney disease. Front. Biosci. 13, 5174-5186
10. Hu, K., Wu, C., Mars, W. M., and Liu, Y. (2007) Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling. J. Clin. Invest. 117, 3821-3832
11. Hu, K., Yang, J., Tanaka, S., Gonias, S. L., Mars, W. M., and Liu, Y. (2006) Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. J. Biol. Chem. 281, 2120-2127
12. Lin, L., Bu, G., Mars, W. M., Reeves, W. B., Tanaka, S., and Hu, K. (2010) tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3β pathway. Am. J. Pathol. 177, 1687-1696
13. Shi, Y., Mantuano, E., Inoue, G., Campana, W. M., and Gonias, S. L. (2009) Ligand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway. Sci. Signal. 2, ra18
14. Lin, L., Wu, C., and Hu, K. (2012) Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase. J. Am. Soc. Nephrol. 23, 1329-1338
15. Lin, L., and Hu, K. (2014) Tissue plasminogen activator and inflammation: from phenotype to signaling mechanisms. Am. J. Clin. Exp. Immunol. 3, 30-36
16. Zhang, C., An, J., Strickland, D. K., and Yepes, M. (2009) The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain. Am. J. Pathol. 174, 586-594
17. Higazi, A. A., El-Haj, M., Melhem, A., Horani, A., Pappo, O., Alvarez, C. E., Muhanna, N., Friedman, S. L., and Safadi, R. (2008) Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis. Clin. Exp. Immunol. 152, 163-173
18. Roelofs, J. J., Rouschop, K. M., Leemans, J. C., Claessen, N., de Boer, A. M., Frederiks, W. M., Lijnen, H. R., Weening, J. J., and Florquin, S. (2006) Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. J. Am. Soc. Nephrol. 17, 131-140
19. Lin, L., Jin, Y., Mars, W. M., Reeves, W. B., and Hu, K. (2014) Myeloid-derived tissue-type plasminogen activator promotes macrophage motility through FAK, Rac1, and NF-κB pathways. Am. J. Pathol. 184, 2757-2767
20. Lin, L., and Hu, K. (2014) LRP-1: functions, signaling and implications in kidney and other diseases. Int. J. Mol. Sci. 15, 22887-22901
21. Rohlmann, A., Gotthardt, M., Willnow, T. E., Hammer, R. E., and Herz, J. (1996) Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nat. Biotechnol. 14, 1562-1565
22. Cao, C., Lawrence, D. A., Li, Y., Von Arnim, C. A., Herz, J., Su, E. J., Makarova, A., Hyman, B. T., Strickland, D. K., and Zhang, L. (2006) Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration. EMBO J. 25, 1860-1870
23. Hu, L., Boesten, L. S., May, P., Herz, J., Bovenschen, N., Huisman, M. V., Berbée, J. F., Havekes, L. M., van Vlijmen, B. J., and Tamsma, J. T. (2006) Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice. Arterioscler. Thromb. Vasc. Biol. 26, 2710-2715
24. Overton, C. D., Yancey, P. G., Major, A. S., Linton, M. F., and Fazio, S. (2007) Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse. Circ. Res. 100, 670-677
25. Lange-Sperandio, B., Trautmann, A., Eickelberg, O., Jayachandran, A., Oberle, S., Schmidutz, F., Rodenbeck, B., Hömme, M., Horuk, R., and Schaefer, F. (2007) Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. Am. J. Pathol. 171, 861-871
26. Zhang, B., Ramesh, G., Uematsu, S., Akira, S., and Reeves, W. B. (2008) TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J. Am. Soc. Nephrol. 19, 923-932
27. Fujiu, K., Manabe, I., and Nagai, R. (2011) Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J. Clin. Invest. 121, 3425-3441
28. Iwata, Y., Boström, E. A., Menke, J., Rabacal, W. A., Morel, L., Wada, T., and Kelley, V. R. (2012) Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice. J. Immunol. 188, 4568-4580
29. Martinez, F. O., Sica, A., Mantovani, A., and Locati, M. (2008) Macrophage activation and polarization. Front. Biosci. 13, 453-461
30. Sica, A., and Mantovani, A. (2012) Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787-795
31. Locati, M., Mantovani, A., and Sica, A. (2013) Macrophage activation and polarization as an adaptive component of innate immunity. Adv. Immunol. 120, 163-184
32. Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., Locati, M., Mantovani, A., Martinez, F. O., Mege, J. L., Mosser, D. M., Natoli, G., Saeij, J. P., Schultze, J. L., Shirey, K. A., Sica, A., Suttles, J., Udalova, I., van Ginderachter, J. A., Vogel, S. N., and Wynn, T. A. (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14-20
33. Sapkota, G. P., Cummings, L., Newell, F. S., Armstrong, C., Bain, J., Frodin, M., Grauert, M., Hoffmann, M., Schnapp, G., Steegmaier, M., Cohen, P., and Alessi, D. R. (2007) BI-D1870 is a specific inhibitor of the p90RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem. J. 401, 29-38
34. Nguyen, T. L. (2008) Targeting RSK: an overview of small molecule inhibitors. Anticancer Agents Med. Chem. 8, 710-716
35. Romeo, Y., Zhang, X., and Roux, P. P. (2012) Regulation and function of the RSK family of protein kinases. Biochem. J. 441, 553-569
36. Yepes, M., Sandkvist, M., Moore, E. G., Bugge, T. H., Strickland, D. K., and Lawrence, D. A. (2003) Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest. 112, 1533-1540
37. Wang, Y. F., Tsirka, S. E., Strickland, S., Stieg, P. E., Soriano, S. G., and Lipton, S. A. (1998) Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat. Med. 4, 228-231
38. Anjum, R., and Blenis, J. (2008) The RSK family of kinases: emerging roles in cellular signalling. Nat. Rev. Mol. Cell Biol. 9, 747-758
39. Carriere, A., Ray, H., Blenis, J., and Roux, P. P. (2008) The RSK factors of activating the Ras/MAPK signaling cascade. Front. Biosci. 13, 4258-4275
40. Raman, M., Chen, W., and Cobb, M. H. (2007) Differential regulation and properties of MAPKs. Oncogene 26, 3100-3112
41. Thornton, T. M., and Rincon, M. (2009) Non-classical p38 MAP kinase functions: cell cycle checkpoints and survival. Int. J. Biol. Sci. 5, 44-51
42. Wang, W., Chen, J. X., Liao, R., Deng, Q., Zhou, J. J., Huang, S., and Sun, P. (2002) Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol. Cell. Biol. 22, 3389-3403